These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 27179404)

  • 1. Transarterial Chemoembolization Using Sorafenib in a Rabbit VX2 Liver Tumor Model: Pharmacokinetics and Antitumor Effect.
    Kim GM; Kim MD; Kim do Y; Kim SH; Won JY; Park SI; Lee do Y; Shin W; Shin M
    J Vasc Interv Radiol; 2016 Jul; 27(7):1086-92. PubMed ID: 27179404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic study of conventional sorafenib chemoembolization in a rabbit VX2 liver tumor model.
    Parvinian A; Casadaban LC; Hauck ZZ; van Breemen RB; Gaba RC
    Diagn Interv Radiol; 2015; 21(3):235-40. PubMed ID: 25835078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transarterial embolization with sorafenib in animal livers: a pharmacokinetics study.
    Chatziioannou AN; Siskos AP; Loxas D; Kavatzas N; Agrogiannis G; Fokas D; Malagari K; Kostomitsopoulos NG; Tsigkou O; Tamvakopoulos C
    J Vasc Interv Radiol; 2013 Nov; 24(11):1657-63.e1. PubMed ID: 24060438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transarterial sorafenib chemoembolization: preliminary study of technical feasibility in a rabbit model.
    Gaba RC; Yap FY; Martinez EM; Li Y; Guzman G; Parvinian A; van Breemen RB; Kumar N
    J Vasc Interv Radiol; 2013 May; 24(5):744-50. PubMed ID: 23510657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemoembolization with Vascular Disrupting Agent CKD-516 Dissolved in Ethiodized Oil in Combination with Doxorubicin: A VX2 Tumor Model Study.
    Lee IJ; Lee M; Kim SJ; Kim YK; Won JY; Chung JW
    J Vasc Interv Radiol; 2018 Aug; 29(8):1078-1084. PubMed ID: 29910164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatocellular necrosis, apoptosis, and proliferation after transcatheter arterial embolization or chemoembolization in a standardized rabbit model.
    Wang Y; Zheng C; Liang B; Zhao H; Qian J; Liang H; Feng G
    J Vasc Interv Radiol; 2011 Nov; 22(11):1606-12. PubMed ID: 21959058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics and Early Tumor Response to Conventional Transarterial Chemoembolization with Sorafenib and Doxorubicin in a VX2 Rabbit Tumor Model.
    Elkhadragy L; Khabbaz RC; Muchiri RN; Totura WM; Samuelson JP; Whiteley HE; van Breemen RB; Lokken RP; Gaba RC
    J Vasc Interv Radiol; 2022 Oct; 33(10):1213-1221.e5. PubMed ID: 35850455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modified transarterial chemoembolization with locoregional administration of sorafenib for treating hepatocellular carcinoma: feasibility, efficacy, and safety in the VX-2 rabbit liver tumor model.
    Seidensticker M; Streit S; Nass N; Wybranski C; Jürgens J; Brauner J; Schulz N; Kalinski T; Seidensticker R; Garlipp B; Steffen I; Ricke J; Dudeck O
    Diagn Interv Radiol; 2016; 22(4):378-84. PubMed ID: 27328720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Transhepatic arterial embolization with superparamagnetic iron oxide and lipiodol for the treatment of VX2 tumor in rabbits].
    Liang Q; Deng L; Feng Z; Liu X; Ding J; Hu P; Wang W
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2017 Nov; 42(11):1248-1256. PubMed ID: 29187650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of transcatheter arterial embolization on levels of hypoxia-inducible factor-1alpha in rabbit VX2 liver tumors.
    Rhee TK; Young JY; Larson AC; Haines GK; Sato KT; Salem R; Mulcahy MF; Kulik LM; Paunesku T; Woloschak GE; Omary RA
    J Vasc Interv Radiol; 2007 May; 18(5):639-45. PubMed ID: 17494846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transarterial administration of integrin inhibitor loaded nanoparticles combined with transarterial chemoembolization for treating hepatocellular carcinoma in a rat model.
    Qian J; Oppermann E; Tran A; Imlau U; Qian K; Vogl TJ
    World J Gastroenterol; 2016 Jun; 22(21):5042-9. PubMed ID: 27275096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-tumor Effects of Sorafenib Administered at Different Time Points in Combination with Transarterial Embolization in a Rabbit VX2 Liver Tumor Model.
    Tomozawa Y; Nitta N; Ohta S; Watanabe S; Sonoda A; Nitta-Seko A; Tsuchiya K; Murata K
    Cardiovasc Intervent Radiol; 2017 Nov; 40(11):1763-1768. PubMed ID: 28593395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A small interfering RNA targeting vascular endothelial growth factor efficiently inhibits growth of VX2 cells and VX2 tumor model of hepatocellular carcinoma in rabbit by transarterial embolization-mediated siRNA delivery.
    Zou Y; Guo CG; Yang ZG; Sun JH; Zhang MM; Fu CY
    Drug Des Devel Ther; 2016; 10():1243-55. PubMed ID: 27069355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transarterial embolization combined with RNA interference targeting hypoxia-inducible factor-1α for hepatocellular carcinoma: a preliminary study of rat model.
    Ni JY; Xu LF; Wang WD; Huang QS; Sun HL; Chen YT
    J Cancer Res Clin Oncol; 2017 Feb; 143(2):199-207. PubMed ID: 27638772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatic arterial administration of sorafenib and iodized oil effectively attenuates tumor growth and intrahepatic metastasis in rabbit VX2 hepatocellular carcinoma model.
    Zhang L; Liu FY; Fu JX; Duan F; Fan QS; Wang MQ
    Int J Clin Exp Pathol; 2014; 7(11):7775-81. PubMed ID: 25550815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multicenter Phase II Clinical Trial of Sorafenib Combined with Transarterial Chemoembolization for Advanced Stage Hepatocellular Carcinomas (Barcelona Clinic Liver Cancer Stage C): STAB Study.
    Sato Y; Nishiofuku H; Yasumoto T; Nakatsuka A; Matsuo K; Kodama Y; Okubo H; Abo D; Takaki H; Inaba Y; Yamakado K
    J Vasc Interv Radiol; 2018 Aug; 29(8):1061-1067. PubMed ID: 29934260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sorafenib in combination with transarterial chemoembolization for the treatment of hepatocellular carcinoma.
    Geschwind JF; Chapiro J
    Clin Adv Hematol Oncol; 2016 Aug; 14(8):585-7. PubMed ID: 27487101
    [No Abstract]   [Full Text] [Related]  

  • 18. Correlation of hypoxia-inducible factor 1alpha with angiogenesis in liver tumors after transcatheter arterial embolization in an animal model.
    Liang B; Zheng CS; Feng GS; Wu HP; Wang Y; Zhao H; Qian J; Liang HM
    Cardiovasc Intervent Radiol; 2010 Aug; 33(4):806-12. PubMed ID: 19937023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of a Glass Membrane Pumping Emulsification Device Improves Systemic and Tumor Pharmacokinetics in Rabbit VX2 Liver Tumor in Transarterial Chemoembolization.
    Masada T; Tanaka T; Nishiofuku H; Fukuoka Y; Taiji R; Sato T; Tatsumoto S; Minamiguchi K; Marugami N; Kichikawa K
    J Vasc Interv Radiol; 2020 Feb; 31(2):347-351. PubMed ID: 31542274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sorafenib With and Without Transarterial Chemoembolization for Advanced Hepatocellular Carcinoma With Main Portal Vein Tumor Thrombosis: A Retrospective Analysis.
    Zhang Y; Fan W; Wang Y; Lu L; Fu S; Yang J; Huang Y; Yao W; Li J
    Oncologist; 2015 Dec; 20(12):1417-24. PubMed ID: 26446238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.